Addressing a topic of utmost importance in the field, this text addresses the epidemiology, diagnosis, assessment, and management of patients with metabolic syndrome-focusing on implications for cardiovascular disease risk. With an abundance of clearly organized tables, flowcharts, and practice guidelines, this blue-ribbon source succinctly analyzes recent clinical trials, compares and assesses recent and emerging therapies, and provides recommendations for the improved assessment and treatment of patients, while supplying a state-of-the-art overview of approaches to optimize and enhance patient care.

This is a highly practical resource focusing on the application of current guidelines and practice standards in the clinical management of cardiovascular risk factors. It reflects the most current information and clinical practices, including the growing number of biomarkers and genetic variants that have greatly changed the understanding of the pathophysiology of cardiovascular risk. The primer presents concise descriptions of each major cardiovascular risk factor, key methodologies in cardiovascular risk assessment, special issues in risk assessment of specific patient populations, and practical, to-the-point discussions of current best practices in clinical management.

The book is authored by 50 recognized leaders in each area of practice, who together provide the most authoritative current information available about current guidelines and practice standards in preventative cardiology. Editors are comprised of current and former officers of the ASPC. Key Features:

Present a highly practical focus on the application of current guidelines and practice standards regarding cardiovascular risk factors Authored by recognized leaders in each cardiology specialty Delineates the steps needed to address specific clinical problems Covers all major cardiovascular risk factors, key methodologies in risk assessment, and special issues regarding specific patient populations